Revance Therapeutics, Inc.Eigentümerstruktur
| Preis (2025-02-06) | 52W Hoch | 52W Tief |
| 3.65 USD | 0 USD | 0 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 7,637 USD | 1 | 0 | 7 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 104.390.000 | 4,96 | 1,7 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Revance Therapeutics, Inc.
Mitarbeiter 597
Handelsplatz NASDAQ
Ticker Symbol RVNC
IPO Datum 2014-02-06
Adresse 1222 Demonbreun Street, Nashville, TN, United States, 37203
Webseite https://www.revance.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Mark J. Foley | CEO & Director |
| 2 | Mr. Tobin C. Schilke | CFO & Principal Accounting Officer |
| 3 | Mr. Dwight O. Moxie J.D. | Chief Legal Officer & General Counsel |
| 4 | Ms. Amie Krause | Chief People Officer |
| 5 | Dr. Conor Gallagher | Head of Medical Affairs & Aesthetics |
| 6 | Dr. David A. Hollander M.B.A., M.D. | Chief Medical Officer of Global Therapeutics Franchise Lead |
| 7 | Ms. Erica Jordan | Chief Commercial Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Beryl Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | ODDO BHF Asset Management SAS | 0,00% | 0,00 Mio. USD |
| 5 | Fidelity International Ltd | 0,00% | 0,00 Mio. USD |
| 6 | AllianceBernstein L.P. | 0,00% | 0,00 Mio. USD |
| 7 | Squarepoint Ops LLC | 0,00% | 0,00 Mio. USD |
| 8 | Magnetar Financial LLC | 0,00% | 0,00 Mio. USD |
| 9 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 10 | Eckert Corp | 0,00% | 0,00 Mio. USD |
| 11 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Glazer Capital, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Newtyn Management LLC | 0,00% | 0,00 Mio. USD |
| 14 | Adage Capital Partners Gp LLC | 0,00% | 0,00 Mio. USD |
| 15 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 16 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 17 | Cnh Partners, LLC | 0,00% | 0,00 Mio. USD |
| 18 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 19 | Qube Research & Technologies | 0,00% | 0,00 Mio. USD |
| 20 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |